Equity
Phantom Stock and SARs: Paying Equity Upside Without Issuing a Single Share
Phantom stock and SARs pay equity upside without issuing shares. How Section 409A, ASC 718 liability accounting, and the valuation decide what it costs.
By 409.AI Team - 2026-08-25
# Phantom Stock and SARs: Paying Equity Upside Without Issuing a Single Share
Picture a 90-person logistics company. The two founders hold 82% between them and have said, more than once, that they won't go below 80%. The board wants to keep six operations leads who could walk into a competitor tomorrow. Nobody on the founding side wants a new shareholder with information rights, a signature line on every written consent, and an opinion about the next financing.
That company doesn't need an option pool. It needs synthetic equity.
Phantom stock and stock appreciation rights pay people as if they owned shares, without ever issuing shares. The cap table doesn't move. The economics do. And because these awards are contractual promises rather than stock, they sit in a different corner of the tax code and a different corner of the accounting standards than the options most founders already understand.
That gap is where these plans usually go wrong, and the stakes have risen as companies stay private longer. [Vanguard](https://corporate.vanguard.com/content/corporatesite/us/en/corp/articles/why-more-growth-happens-before-the-ipo.html) puts the median age of a company at IPO at roughly six years in the 1980s, rising to a peak of 15 years in 2022. A ten-year option term stops looking generous when the liquidity event is twelve years out.
Two instruments that people treat as one
A phantom stock unit tracks the full value of a share. Grant 1,000 units when common stock is worth $4.00, and if the company is sold five years later at $18.00 per share, the holder is owed $18,000.
A stock appreciation right tracks only the increase. Same grant, same exit, and the holder is owed $14,000: the $18.00 exit value less the $4.00 base price, times 1,000.
Both usually settle in cash. Both can be written to settle in stock, which changes the analysis considerably, and we'll come back to that.
The choice is not cosmetic. A SAR pays nothing unless the company is worth more than it was on the grant date, exactly how an option behaves. Phantom stock pays out even if the company goes sideways, which makes it closer to a deferred cash bonus indexed to enterprise value. Boards that grant phantom units thinking they've granted "options without the paperwork" tend to be surprised by the first payout.
Section 409A treats them very differently
Settle this before anyone drafts a plan document, because the two instruments diverge here completely.
Section 409A of the Internal Revenue Code governs nonqualified deferred compensation. When a plan violates it, the consequences fall on the employee, not the company: all deferred amounts not subject to a substantial risk of forfeiture become includible in gross income, plus a 20% additional tax on that amount, plus interest computed at the underpayment rate plus one percentage point ([26 U.S.C. §409A(a)(1)](https://www.law.cornell.edu/uscode/text/26/409A)). An employee can owe tax on money they have not received.
SARs can sit outside 409A entirely
Treasury regulation [§1.409A-1(b)(5)(i)(B)](https://www.law.cornell.edu/cfr/text/26/1.409A-1) says a stock appreciation right does not provide deferred compensation if three things are true. The payout can't exceed the excess of the stock's fair market value at exercise over an amount fixed at grant, on a fixed number of shares. The base price is never less than fair market value on the grant date. And the right carries no deferral feature beyond deferring income recognition until exercise.
Meet those conditions on service recipient stock and the SAR is exempt. Notably, the final regulations extended this exemption to cash-settled SARs, not just stock-settled ones, which is why a well-drafted cash SAR program can stay out of 409A's payment-timing machinery altogether.
The catch is the base price. "Never less than fair market value on the date of grant" means the entire exemption rests on a defensible valuation. The same regulation, at §1.409A-1(b)(5)(iv)(B)(2), describes when a private company's valuation is presumed reasonable: an independent appraisal meeting the ESOP standard in §401(a)(28)(C) and dated within the previous 12 months, or, for an illiquid start-up corporation that has not conducted a trade or business for 10 years or more, a written valuation made reasonably and in good faith by someone with at least five years of relevant experience in business valuation, financial accounting, investment banking, private equity, or secured lending.
If that language sounds familiar, it should. It's the same presumption that backs the strike price on a normal option grant, which is why a SAR program runs on the same [409A valuation](https://www.409.ai/products/409a) cadence as an option plan. Most companies refresh annually or after a material event; our guide on [how often you need a 409A](https://www.409.ai/articles/409a-valuation-frequency-how-often-should-you-get-one) walks through what counts as material.
Phantom stock almost always lands inside 409A
Full-value phantom units have no appreciation-only limitation, so the SAR exemption is unavailable. They are deferred compensation, and the plan has to pick its payment triggers from the statutory list in §409A(a)(2)(A): separation from service, disability, death, a specified time or fixed schedule set at the date of deferral, a change in ownership or effective control, or an unforeseeable emergency.
"When the board decides the company can afford it" is not on that list. Neither is "on written request from the participant." Plans that let executives pull money out on demand are the classic failure, and the tax falls on the executive.
None of this makes phantom stock a bad instrument. It makes it a documented one. If you want the broader picture of how these arrangements are structured and administered, we covered it in [409A nonqualified deferred compensation plans](https://www.409.ai/articles/409a-nonqualified-deferred-compensation-plans).
The accounting is where CFOs get ambushed
Options granted to employees are measured once, at grant-date fair value, and that number never moves again. Cash-settled phantom units and SARs don't work that way.
Because the company must settle in cash, the award is liability-classified under ASC 718. The liability is remeasured at every reporting date until settlement, and the change runs through compensation expense.
Work the numbers. A company grants 100,000 phantom units when common stock is worth $4.00, vesting over four years. At the first year end, the units are 25% vested and common is worth $6.00, so the accrued liability is roughly $150,000 and the year's expense is $150,000. The next year the company raises a strong round and common reaches $11.00. Now 50% is vested, the liability is about $550,000, and the second year absorbs $400,000 of expense. Then growth stalls, common drifts to $8.00, and at 75% vested the liability falls to $600,000. That year takes only $50,000, because the value decline claws back expense already recognized.
Nothing about the awards changed. The expense swung from $150,000 to $400,000 to $50,000 because the share price moved. Equity-classified options would have shown a flat, predictable charge. If your board reads compensation expense as a signal about hiring discipline, someone should explain the mechanic before the first surprise.
There is a release valve for private companies. A nonpublic entity can elect, as an accounting policy applied consistently across its liability-classified awards, to measure them at intrinsic value rather than full fair value. The awards still get remeasured every reporting period, but intrinsic value removes the option-pricing model from the exercise. It doesn't remove the earnings volatility. Our [ASC 718 guide for startups](https://www.409.ai/articles/asc-718-stock-based-compensation-startup-guide) covers how the underlying expense mechanics work, and an [ASC 718 valuation](https://www.409.ai/products/asc-718) is what supports the number in either case.
One design point follows directly: a SAR that must be settled in shares, on a fixed number of shares, is generally equity-classified and escapes the remeasurement treadmill. If the earnings volatility is the objection rather than the dilution, stock settlement is the lever.
The tax bill is ordinary income, start to finish
A phantom or SAR payout is compensation. It is taxed as ordinary income at wage rates, reported on Form W-2, and subject to withholding. There is no long-term capital gains path, no matter how long the units were held. There is no qualified small business stock exclusion, because [Section 1202](https://www.409.ai/articles/qsbs-one-big-beautiful-bill-act-section-1202-changes) requires actual stock and a phantom unit is a contract. There is no [83(b) election](https://www.409.ai/articles/the-83b-election-explained-for-founders) available either, since §83 governs transfers of property and an unfunded promise to pay isn't a transfer.
Compare that with an incentive stock option held through the required periods, where the entire spread can be taxed at capital rates. The difference is the reason our breakdown of [how ISOs and NSOs are taxed](https://www.409.ai/articles/iso-vs-nso-how-stock-options-are-taxed) matters here: a phantom unit is economically closest to an NSO, and worse on the tax side than an ISO.
Payroll taxes run on their own clock. Under §3121(v)(2) and [Treasury regulation §31.3121(v)(2)-1(a)(2)](https://www.law.cornell.edu/cfr/text/26/31.3121%28v%29%282%29-1), amounts deferred under a nonqualified plan are taken into account for FICA at the later of when the services are performed or when the amount stops being subject to a substantial risk of forfeiture. Social Security and Medicare tax can therefore come due at vesting, years before any cash changes hands. The offsetting benefit is the non-duplication rule: once an amount has been taken into account, neither it nor the earnings attributable to it are treated as FICA wages again. Vest a large tranche in a year when the employee has already cleared the Social Security wage base and the Medicare portion is often all that's left.
For the company, the deduction arrives when the employee includes the payment in income, which is a mismatch worth modeling if the payout year is also the exit year.
When synthetic equity is the right answer
It fits when the ownership structure is the constraint. Family businesses that will never sell. Companies with a controlling shareholder who won't dilute. Foreign employees where issuing local shares creates a tax mess. Subsidiaries where you want people tracking the parent's value without becoming parent shareholders. In all of these, the alternative isn't options, it's nothing.
It fits poorly when employees expect real ownership and would notice the difference. A synthetic award gives no vote, no preemptive rights, no capital gains treatment, and no claim in a liquidation beyond an unsecured contractual promise. If the company files for bankruptcy, phantom holders are general creditors.
For an LLC, run the comparison against profits interests before defaulting to phantom units. A properly structured profits interest can deliver capital gains treatment that no phantom plan can match, though it turns members into partners and brings K-1s with it. We laid out that trade-off, and the hurdle valuation it depends on, in [profits interests and the hurdle valuation](https://www.409.ai/articles/profits-interests-llc-equity-hurdle-valuation).
What actually decides whether the plan works
Every part of a synthetic equity program routes back to one number: what a share of common stock is worth. The SAR base price has to equal it at grant or the 409A exemption evaporates. The liability on the balance sheet is remeasured against it at every reporting date. The payout at exit is computed from it. And a formula written into a plan document in 2019, something like six times trailing EBITDA, will drift from economic reality and become the thing people argue about when the money is real.
Companies that treat the valuation as the foundation of the plan, rather than an administrative chore attached to it, are the ones whose phantom programs pay out without a dispute. The plan document is the easy part. Ask what the units are worth, on a schedule, before anyone needs the answer.